Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panel
Light transmission aggregometry (LTA) is used worldwide for the investigation of
Blood
How I treat anticoagulated patients undergoing an elective procedure or surgery
10:49
סגור לתגובות על How I treat anticoagulated patients undergoing an elective procedure or surgery
The periprocedural management of patients receiving long-term oral anticoagulant therapy remains
How I treat transfusional iron overload
12:17
סגור לתגובות על How I treat transfusional iron overload
Patients with ?-thalassemia major (TM) and other refractory anemias requiring regular
How I treat relapsed childhood acute lymphoblastic leukemia
12:31
סגור לתגובות על How I treat relapsed childhood acute lymphoblastic leukemia
The most common cause of treatment failure in childhood acute lymphoblastic
How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment
12:22
סגור לתגובות על How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment
The paradigm for managing primary immune thrombocytopenia (ITP) in adults has
How I treat polycythemia vera
12:29
סגור לתגובות על How I treat polycythemia vera
Polycythemia vera (PV) is a clonal disorder characterized by unwarranted production
How I treat pediatric acute myeloid leukemia
11:16
סגור לתגובות על How I treat pediatric acute myeloid leukemia
Acute myeloid leukemia is a heterogeneous disease that accounts for approximately
How I treat acquired aplastic anemia
11:27
סגור לתגובות על How I treat acquired aplastic anemia
Survival in severe aplastic anemia (SAA) has markedly improved in the
How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch
11:22
סגור לתגובות על How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch
wo novel oral anticoagulants, dabigatran and rivaroxaban, have recently been approved.
How I treat heparin-induced thrombocytopenia
11:49
סגור לתגובות על How I treat heparin-induced thrombocytopenia
Heparin-induced thrombocytopenia is a prothrombotic adverse drug effect induced by platelet-activating antibodies against multimolecular complexes of platelet factor 4
